ClinicalTrialsFinder

Refractory Desmoplastic Small Round Cell Tumor Clinical Trials in Birmingham, Alabama

1 recruitingBirmingham, Alabama

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

OsteosarcomaRecurrent OsteosarcomaWilms Tumor+5 more
National Cancer Institute (NCI)55 enrolled28 locationsNCT04616560